Manulife (Manufacturers Life Insurance)’s LENZ Therapeutics LENZ Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,816	Closed	-$335K	–	2926
2025 Q4	$335K	Sell	20,816 -172	-0.8%	-$5.01K	﹤0.01%	2324
2025 Q3	$978K	Buy	+20,988	New	+$772K	﹤0.01%	1865
2025 Q2	–	Sell	-42,230	Closed	-$1.09M	–	3016
2025 Q1	$1.09M	Sell	42,230 -25,661	-38%	-$632K	﹤0.01%	1775
2024 Q4	$1.96M	Buy	67,891 +36,582	+117%	+$1.12M	﹤0.01%	1564
2024 Q3	$743K	Buy	+31,309	New	+$695K	﹤0.01%	2073
2022 Q2	–	Sell	-1,799	Closed	-$64.2K	–	3159
2022 Q1	$64.2K	Buy	+1,799	New	+$113K	﹤0.01%	3022

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LENZ Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 20,816 shares — an estimated $335K sold.

Manulife (Manufacturers Life Insurance) first reported a position in LENZ in Q1 2022 and held it in 6 quarters. The position peaked at $1.96M in Q4 2024. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

Manulife (Manufacturers Life Insurance) reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 20,816 LENZ Therapeutics shares in Q1 2026, an estimated $335K.
Manulife (Manufacturers Life Insurance) first reported a position in LENZ Therapeutics in Q1 2022 and held it in 6 quarters.
Manulife (Manufacturers Life Insurance)'s LENZ Therapeutics position peaked at $1.96M in Q4 2024.
145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.